Related Experiment Video
Updated: Jul 16, 2026

Visualizing the DNA Damage Response in Purkinje Cells Using Cerebellar Organotypic Cultures
Published on: December 27, 2024
PRMT5 inhibition disrupts detained intron splicing and impairs ATR signaling with increased DNA damage
Camille H Cushman1,2,3, Colin E Fowler4,5,6, Chiara Mazziotta1,7
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Abstract:
PRMT5 catalyzes symmetric dimethyl arginine on numerous proteins, with PRMT5 inhibitors (PRMT5i) inducing anti-proliferative effects in preclinical studies. Several models have been proposed to explain sensitivity to PRMT5i including through p53 activation and DNA damage response (DDR) regulation. Here, we interrogate the mechanisms of PRMT5i sensitivity in Merkel cell carcinoma, a neuroendocrine skin cancer sensitive to p53 activation. To identify critical pathways altered by PRMT5i, we performed CRISPR/Cas9 screening, proteomic, and transcriptomic analyses. Our results indicate that PRMT5i sensitivity is independent of p53 activation and is characterized by an increase in detained introns (DIs) and dependency on mRNA processing factors. Sensitivity correlated with elevated basal DI levels and was associated with replication-associated DNA damage accompanied by impaired ATR/CHK1 signaling. These findings are consistent with a threshold model of sensitivity in which excessive DI accumulation is associated with replication-associated DNA damage and apoptosis following PRMT5 inhibition.
Insights
PRMT5 inhibitors (PRMT5i) cause cancer cell death by increasing detained introns (DIs), impacting mRNA processing. Sensitivity is linked to DNA damage and impaired signaling, not p53 activation.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genetics
Background:
- Protein arginine methyltransferase 5 (PRMT5) inhibition shows anti-proliferative effects.
- Proposed mechanisms for PRMT5 inhibitor (PRMT5i) sensitivity involve p53 activation and DNA damage response (DDR).
Purpose of the Study:
- To investigate the mechanisms of PRMT5i sensitivity in Merkel cell carcinoma.
- To identify pathways critical for PRMT5i sensitivity independent of p53 activation.
Main Methods:
- CRISPR/Cas9 screening
- Proteomic analysis
- Transcriptomic analysis
Main Results:
- PRMT5i sensitivity is independent of p53 activation.
- PRMT5i treatment increases detained introns (DIs) and dependency on mRNA processing factors.
- Sensitivity correlates with elevated basal DI levels, replication-associated DNA damage, and impaired ATR/CHK1 signaling.
Conclusions:
- PRMT5i sensitivity in Merkel cell carcinoma is linked to accumulated DIs and impaired DNA damage response.
- A threshold model explains sensitivity, where excessive DI accumulation leads to DNA damage and apoptosis upon PRMT5 inhibition.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Restarting Stalled Replication Forks
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Regulation of the Unfolded Protein Response

